4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,028.00p
   
  • Change Today:
    -7.00p
  • 52 Week High: 1,070.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 0
  • Market Cap: £131.64m

Latest ShareCast News

4basebio to provide synthetic DNA to tier-one pharma firm

By Josh White

Date: Wednesday 10 Apr 2024

(Sharecast News) - 4basebio confirmed the provision of its synthetic DNA to an unnamed tier-one pharmaceutical company on Wednesday.

4basebio client gets approval to start trial in Australia

By Josh White

Date: Thursday 21 Mar 2024

(Sharecast News) - Synthetic DNA product developer 4basebio announced on Thursday that its client, Helix Nanotechnologies, has achieved a significant milestone with the receipt of HREC approval in Australia.

4basebio inks significant DNA supply contract

By Josh White

Date: Friday 01 Mar 2024

(Sharecast News) - 4basebio announced a significant contract through a competitive tender process on Friday, to provide research and GMP-grade synthetic DNA for the advancement of RNA therapeutics and vaccines at CPI's RNA Centre of Excellence.

First-half losses narrow for 4basebio 21-Sep-2023 ShareCast
4basebio inks supply deal with Italy's Neomatrix 25-May-2023 ShareCast
4basebio enters neurofibromatosis collaboration ... 10-Jun-2022 ShareCast
Losses to continue as 4basebio focuses on commer... 09-May-2022 ShareCast
4basebio inks development deal with Heqet Therap... 27-Apr-2022 ShareCast
4basebio launches two new synthetic DNA products 23-Mar-2022 ShareCast
4basebio makes progress with manufacturing devel... 15-Feb-2022 ShareCast
4basebio enters research collaboration with eThe... 18-Jan-2022 ShareCast
4basebio enters development deal with T-cell the... 23-Nov-2021 ShareCast
4basebio files for patent on novel DNA type 22-Jun-2021 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,028.00p
Change Today -7.00p
% Change -0.68 %
52 Week High 1,070.00
52 Week Low 500.00
Volume 0
Shares Issued 12.81m
Market Cap £131.64m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.39% below the market average70.39% below the market average70.39% below the market average70.39% below the market average70.39% below the market average
28.3% below the sector average28.3% below the sector average28.3% below the sector average28.3% below the sector average28.3% below the sector average
Price Trend
97.59% above the market average97.59% above the market average97.59% above the market average97.59% above the market average97.59% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
35.42% below the market average35.42% below the market average35.42% below the market average35.42% below the market average35.42% below the market average
51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average51.35% below the sector average

4basebio Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page